Thank you, John, and good morning to everyone on the call today. I will begin on Slide 4 with a review of our safety performance. For fiscal year 2024, our total case incident rate was 1.8. Although a 1.8 injury rate was ranked as one of the safest metal manufacturing companies, it is not a rate we accept at Carpenter Technology. Our goal is to be a zero injury workplace. As we enter fiscal year 2025, we continue to believe our zero injury goal is possible and we will continue to invest and work tirelessly to achieve that goal. Now let's turn to Slide 5 for an overview of our fourth quarter performance. Carpenter Technology continues to exceed growth expectations. In the fourth quarter of fiscal year 2024, we generated $125 million in adjusted operating income, the most profitable quarter on record, beating our previous guidance by approximately 12%. To put this in perspective, it is a 39% increase over our then record sequential third quarter and double our fourth quarter a year-ago. Further, we generated $142.4 million of adjusted free-cash flow during the quarter. The strong fourth quarter performance is a result of continued improvement in productivity, product mix optimization, and pricing actions. The SAO segment exceeded expectations, delivering $140.9 million in operating income, well above the outlook we provided on last quarter's call, and 36% above the sequential third quarter performance. Notably, SAO achieved adjusted operating margin of 25.2%. This is a meaningful step-up from the 21.4% in the previous quarter and our pre-COVID best of approximately 20%. With this exceptional performance, we finished fiscal year 2024 with $354.1 million in adjusted operating income, an annual earnings record for Carpenter Technology. Let's turn to Slide 6 and take a closer look at our fourth quarter sales and market dynamics. In the fourth quarter of fiscal year 2024, sales increased 15% sequentially on higher volumes, improving product mix, and higher realized pricing. Notably, the SAO segment saw a sequential increase in shipments of 13%, the result of increased productivity across facilities, particularly at key melt work centers. You may recall that we previously identified these productivity efforts as a driver of our anticipated second-half performance. We were able to accelerate these efforts as seen in our third quarter performance and then exceed them again for the fourth quarter. With demand for our premium material solutions well-above supply levels across our end-use markets, we continue to remain focused on allocating capacity to where customers value it most. In the fourth quarter, sales to our largest end-use market, Aerospace and Defense, were up 19% sequentially and up 28% year-over-year. Let me dive a bit deeper into the aerospace market. First, it's important to note that industry demand remains robust as measured by passenger traffic, airline miles, and airline operators' desire for new planes. The backlog for commercial airplane bills reported by Boeing and Airbus is now over 15,000 planes or roughly nine years of demand. Again, fundamental dynamics are driving demand. More people than ever in history want to travel and airline operators want the newest generation of airplanes to replace aging fleets, to realize the fuel efficiency they provide, and to meet the additional needed capacity for more airline miles. Today, there is some noise in the supply-chain about build rate attainment and regular news about the timing of production goals. Let me talk about what all that means as we think about our outlook. Carpenter Technology is a key supplier into the aerospace supply-chain with broad exposure to aerospace platforms. This includes narrow-body and wide-body, Airbus and Boeing and MRO and OEM. We like the rest of the supply chain are managing through the current build rate adjustments. Often, even before information is broadly communicated externally, our customers are talking to us about issues they are facing and changes they may need to make. For example, as new bills have lagged, MRO demand remains elevated. As a result, customers may prioritize a different portfolio of products in the near-term. We also have a large backlog of orders, both in aerospace and other markets like defense, energy, and medical. Our broad supply-chain exposure and visibility into future customer needs gives us the flexibility to adjust our production schedules to meet the evolving demands of our customers. Further, despite ongoing increases in our production rate, we still have substantial portions of our backlog wanted earlier by customers, which gives us the opportunity to pull-in orders when needed. Changes to near-term build rates are clearly something we are aware of and will continue to react to and adjust for if and when needed. To bring it all together, there are four important points you should take-away from my comments. One, due to our broad reach of products and capabilities, we are currently able to navigate any near-term adjustments in the aerospace supply-chain due to build rate changes. Two, our backlog remains at record levels. And despite ongoing efforts to limit orders to maintain lead times, we had high order intake across markets in the fourth quarter. Three, even with modest assumption for build rate increases over the next 12 months, we are still increasing our earnings outlook, as I will discuss shortly. And four, looking beyond the next 12 months, we see significantly higher demand on the horizon. We and most others in the industry are confident that there will be ongoing build rate increases, given an extraordinary current and increasing future demand. Moving to the defense market, our customers continue to request emergency orders to support elevated military activity levels due to ongoing world events. We will continue to prioritize these orders given the essential nature of our support. In our medical end-use market, we saw another record quarter with sales up 9% sequentially and 38% year-over-year. Our customers continue to see strong market demand-based on robust procedure backlogs. Like aerospace, our medical customers are focused on securing their much needed supply given the strong demand environment, and view specialty materials as a key strategic area. In addition, customer engagement on new products remains high, driven by innovation in the use of robotics, increasing adoption of less invasive surgeries, and alloy sensitivities, among others. As a result, we continue to see high growth opportunities in the medical industry. Taken together, our aerospace and defense and medical end-use markets are nearly three quarters of our overall business and continue to grow in share. Across our other end-use markets, customer engagement is high and demand for our premium solutions remains positive. For example, we are seeing strong demand for power generation, which drove a 31% sequential sales increase in the energy end-use market. Bottom line is that we are operating in a strong market and we anticipate that to continue and expand in the long-term. Now, I will turn it over to Tim for the financial summary.